SCHEMBL29555104

SCHEMBL29555104

O=C(O)N1CC=C(c2cccc(OCc3ccccc3)n2)CC1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 2/20 0.49
▸ CDK9 P50750 2/20 0.42
▸ ALDH1A1 P00352 4/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ GRM5 P41594 4/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ GRM1 Q13255 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ TNK2 Q07912 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16291515 1.00 PRMT5 (0.49) PRMT5CDK9ALDH1A1SMN1; SMN2GRM5
SCHEMBL24265543 0.90 GRM5 (0.52) PRMT5ALDH1A1SMN1; SMN2GRM5MEN1
SCHEMBL29574203 0.90 GRM5 (0.52) PRMT5ALDH1A1SMN1; SMN2GRM5MEN1
SCHEMBL29518255 0.87 GRM1 (0.56) PRMT5GRM5GRM1TNK2
SCHEMBL15146264 0.87 GRM1 (0.56) PRMT5GRM5GRM1TNK2
SCHEMBL20280123 0.82 GABRA5 (0.42) PRMT5
SCHEMBL16422799 0.82 GRM1 (0.41) PRMT5ALDH1A1SMN1; SMN2GRM5MEN1
SCHEMBL16107429 0.82 PIM1 (0.47) PRMT5CDK9ALDH1A1SMN1; SMN2GRM5
SCHEMBL26914039 0.80 GLP1R (0.49) —
SCHEMBL25169744 0.80 PRMT5 (0.44) PRMT5CDK9ALDH1A1SMN1; SMN2GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022199458-A1 THIOPHENE GLP-1 RECEPTOR AGONIST AND USE THEREOF 杭州中美华东制药有限公司 2022-09-29 — — WO disclosed
WO-2022078152-A1 BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF 杭州中美华东制药有限公司 2022-04-21 — — WO disclosed
Send feedback